RPTX – repare therapeutics inc. - common shares (US:NASDAQ)
Stock Stats
News
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib [Yahoo! Finance]
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Repare Therapeutics Inc. (NASDAQ: RPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
Form SC 13G/A Repare Therapeutics Inc. Filed by: Redmile Group, LLC
Form SC 13G/A Repare Therapeutics Inc. Filed by: Blue Owl Capital Holdings LP
Form SC 13G/A Repare Therapeutics Inc. Filed by: Deep Track Capital, LP
Form 424B5 Repare Therapeutics Inc.
Form 10-Q Repare Therapeutics Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.